Executive record

John Bathery

Director at InMed Pharmaceuticals Inc.

Follow
More
Challenge a Claim

Alpha ID: alpha:person:john-batheryVersion: public-0As of: 2026-09-30

Not yet claimed9 published Claims3 sources
  • Director

Key Claims

Biography

Over 30 years of pharmaceutical industry experience with more than 15 years in corporate development and partnership responsibilities. Currently Head of Global Business Development Operations & Externalization at Takeda Pharmaceuticals. Proven record closing M&A, in-licensing, out-licensing, and divestment transactions exceeding $60 billion in financial terms.

Alpha editorial summary written from the cited sources below. It does not change any Claim on this record.

Board service

Boards

Claims

Executive career

  1. Dates not publishedExecutive title: Head, Global Business Development Operations & Externalization · Organization not publishedINM DEF 14A director slate

Claims

Conflicts and accountability

Alpha has not published independence, related-party, proceedings or disciplinary Claims for this record. This is not a finding that none exist.

Only disclosed facts and public registers appear here. Executive records carry no credit, personal litigation, background screening or underwriting views. None observed is not a clearance.

Evidence, history and coverage

Additional published Claims

Published evidence records

3 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.

  1. INM DEF 14A director slate

    sec filing · Source published: Nov 3, 2025 · Retrieved: May 16, 2026

    Supports 7 claims
    • AI and ML experience: AI and ML experience: not identified in the cited filing · Claim reviewed: May 16, 2026
    • Board role: Board role: Director · Claim reviewed: May 16, 2026
    • Committee assignments: No committee assignment disclosed in the cited filing · Claim reviewed: May 16, 2026
    • Cybersecurity experience: Cybersecurity experience: not identified in the cited filing · Claim reviewed: May 16, 2026
    • Executive company: Executive at Takeda Pharmaceuticals · Claim reviewed: May 16, 2026
    • Executive title: Executive title: Head, Global Business Development Operations & Externalization · Claim reviewed: May 16, 2026
    • Technology background: Technology background: not identified in the cited filing · Claim reviewed: May 16, 2026

  2. Open source

    sec proxy · Source published: Nov 3, 2025 · Retrieved: Apr 28, 2026

    Supports 1 claim
    • Professional Role: Director at InMed Pharmaceuticals Inc. · Claim reviewed: May 16, 2026

  3. Open source

    public source · Source published: Date unavailable · Retrieved: Date unavailable

    Supports 1 claim
    • Board membership: Serves on the board of InMed Pharmaceuticals Inc. · Claim reviewed: May 16, 2026